Butterfly Needle Sets Market Size (2024 - 2029)

The butterfly needle sets market is projected to experience significant growth over the forecast period, driven by an increasing demand for blood and IV infusions due to the rising burden of chronic diseases. The market's expansion is supported by the growing need for medication delivery and blood transfusions, particularly in the context of complications arising from COVID-19 infections. Government initiatives and blood donation campaigns are also contributing to the market's growth. However, the market's potential expansion may be hindered by a lack of innovation and development among key industry players.

Market Size of Butterfly Needle Sets Industry

Butterfly Needle Sets
Study Period 2019 - 2029
Market Size (2024) USD 230 Million
Market Size (2029) USD 450 Million
CAGR (2024 - 2029) 8.20 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Butterfly Needle Sets Market Major Players

*Disclaimer: Major Players sorted in no particular order

Butterfly Needle Sets Market Analysis

The Butterfly Needle Sets Market size is estimated at USD 230 million in 2024, and is expected to reach USD 450 million by 2029, growing at a CAGR of 8.20% during the forecast period (2024-2029).

The studied market witnessed a short-term impact due to the decreased patient visits to hospitals and clinics during the initial phase of the COVID-19 outbreak. According to a research study published in the Journal of Clinical Apheresis in December 2021, therapeutic plasma exchange (TPE) for neuroimmunological disorders played an increasingly important role within the Southeast Asian (SEA) region, but during the pandemic, the procedures were slowed down. This created challenges for the adoption of butterfly needle sets used for blood transfusion and interrupted the growth of the market studied for a shorter term during the initial phases of the pandemic.

However, during the later phases of the pandemic, owing to the increasing burden of complications among multimorbid patients with COVID-19 infections, the demand for medication delivery, IV infusions, and blood transfusions increased. In addition, butterfly needles were also used for delivering medications (such as pain medications) straight into a vein or infusing IV therapies (such as chemotherapy or antibiotics) intravenously, which significantly contributed to the market growth and is anticipated to drive the growth of the market studied over the forecast period.

The butterfly needle sets market is projected to witness significant growth owing to the factors such as an increase in the burden of various chronic diseases such as leukemia and sickle cell disease, along with a rise in demand for blood and IV infusions across the globe.

Government agencies control the measure of blood transfusions and donations due to the increasing burden of leukemia and other blood disorders across countries worldwide. According to the American Cancer Society data updated in January 2023, there will be nearly 59,610 new cases of leukemia, among which 18,740 cases will be chronic lymphocytic leukemia, and 20,380 will be acute myeloid leukemia in the United States. This shows a high burden of disease in the country, which is expected to create a demand for blood transplantations and transfusions, creating demand for butterfly needle sets used for the procedures, driving the studied market growth.

Furthermore, the increasing number of blood donation campaigns and initiatives by government and private organizations is expected to contribute to the overall growth of the market studied. As per an article published by Fresenius Kabi in July 2022, Fresenius Kabi China has been organizing nationwide blood donation activities with an increasing number of participants every year for the past 10 years, and more than 4,000 employees and their family members participated and donated more than 404,000 units of whole blood during these donation activities.

In addition, on World Blood Donor Day 2022, this activity was held in 54 cities across China, and nearly 1,500 or more employees and their family members donated approximately 137,000 units of whole blood. Thus, such activities are further expected to create opportunities for the butterfly needle sets used for blood transfusion procedures and fuel the growth of the market studied.

However, the lack of product innovation and development by major players in the market is expected to hamper market growth over the analysis period.

Butterfly Needle Sets Industry Segmentation

A butterfly needle is a tool used to open a vein so that blood may be drawn or drugs can be administered. A butterfly needle may also be referred to as a "winged infusion set" or "scalp vein set". The butterfly needle sets market is segmented by type of needle gauges (21G butterfly needles, 23G butterfly needles, and other types of needle gauges), application (venipuncture, medicine delivery, blood transfusion, and IV infusions), end-user (hospitals, blood banks, pathology labs, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally.

The report offers the value (in USD) for the above segments.

By Type of Needle Gauges
21G butterfly needles
23G butterfly needles
Other Types of Needle Gauges
By Aplication
Venipuncture
Medicine Delivery
Blood Transfusion
IV Infusion
By End-User
Hospitals
Blood Banks
Pathology Labs
Other End-Users
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Butterfly Needle Sets Market Size Summary

The butterfly needle sets market is poised for substantial growth over the forecast period, driven by an increasing demand for blood and IV infusions globally. The market experienced a temporary setback during the initial phases of the COVID-19 pandemic due to reduced patient visits to healthcare facilities. However, as the pandemic progressed, the demand for butterfly needles surged, fueled by the need for medication delivery and blood transfusions among COVID-19 patients with comorbidities. The rising prevalence of chronic diseases such as leukemia and sickle cell disease, coupled with the growing number of blood donation campaigns, is expected to further propel market expansion. Government regulations and initiatives to manage blood transfusions and donations are also contributing to the market's growth trajectory.

In the Asia-Pacific region, the butterfly needle sets market is anticipated to witness significant growth due to the increasing incidence of diseases like cancer and cardiovascular disorders, which necessitate blood transfusions. Countries such as China, Japan, and India are expected to hold substantial market shares, driven by their high demand for transfusion procedures. The market is moderately competitive, with major players like Cardinal Health, B. Braun Melsungen AG, and Terumo Corporation dominating the landscape. Innovations and developments in butterfly needle sets, along with strategic initiatives by key players, are likely to create new opportunities and enhance market dynamics. Despite challenges such as a lack of product innovation, the overall outlook for the butterfly needle sets market remains positive, with promising growth prospects anticipated in the coming years.

Explore More

Butterfly Needle Sets Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Chronic Diseases

      2. 1.2.2 Increasing Demand for Blood Transfusions and IV infusions

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Product Innovation and Development

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type of Needle Gauges

      1. 2.1.1 21G butterfly needles

      2. 2.1.2 23G butterfly needles

      3. 2.1.3 Other Types of Needle Gauges

    2. 2.2 By Aplication

      1. 2.2.1 Venipuncture

      2. 2.2.2 Medicine Delivery

      3. 2.2.3 Blood Transfusion

      4. 2.2.4 IV Infusion

    3. 2.3 By End-User

      1. 2.3.1 Hospitals

      2. 2.3.2 Blood Banks

      3. 2.3.3 Pathology Labs

      4. 2.3.4 Other End-Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 United Kingdom

        2. 2.4.2.2 France

        3. 2.4.2.3 Germany

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 India

        2. 2.4.3.2 China

        3. 2.4.3.3 Japan

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Butterfly Needle Sets Market Size FAQs

The Butterfly Needle Sets Market size is expected to reach USD 230 million in 2024 and grow at a CAGR of 8.20% to reach USD 450 million by 2029.

In 2024, the Butterfly Needle Sets Market size is expected to reach USD 230 million.

Butterfly Needle Sets Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)